KAS
HELP

Kestra Advisory Services’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Kestra Advisory Services’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-744
Closed -$7.67K – 2594
2024
Q2 		$7.67K Buy
+744
New +$9.74K ﹤0.01% 2606

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Kestra Advisory Services's HELP Position: Q3 2024 in Review

Kestra Advisory Services sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 744 shares — an estimated $7.67K sold.

Kestra Advisory Services first reported a position in HELP in Q2 2024 and held it in 1 quarter. The position peaked at $7.67K in Q2 2024. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Kestra Advisory Services reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 744 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $7.67K.
  • Kestra Advisory Services first reported a position in Helus Pharma Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Kestra Advisory Services's Helus Pharma Inc. Common Stock position peaked at $7.67K in Q2 2024.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Kestra Advisory Services's 13F filing for Q3 2024, filed 13 Nov 2024.